Colour enhancement

From PsychonautWiki
(Redirected from Property:Colour enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
3C-E
Experience:250mg DXM - DXM Itch and Trip Report
25N-NBOMe
Coluracetam
2C-P
5-MeO-MiPT
25I-NBOMe
TMA-6
DOB
4-HO-MET
Experience:120mg - Garden of The Gods
Escaline
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Tree.jpgJapanese Garden by Anonymous
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:BK-2C-B - Various experiences
4-AcO-MET
Experience:337mg DMT fumarate - A Day With DMT
Experience:1000 Morning Glory seeds - Rediscovering the Self
25C-NBOH
Experience:40mg - Brothermind and the Forest's Hand
LSD
Phenylpiracetam
Pregabalin
Allylescaline
6-APB
Oxiracetam
2C-B-FLY
Pramiracetam
Ayahuasca
MDAI
Chameleon.jpgChameleon by Anonymous.
2C-C
3-MeO-PCE
2C-T-21
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
4-AcO-MiPT
LSZ
2C-D
5-MeO-DiBF
Experience:3g mimosa / 3g syrian rue - Connecting with my body
4-HO-MiPT
4-AcO-DMT
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Psilocybin mushrooms
Βk-2C-B
4-AcO-DET
6-APDB
Bufotenin
1B-LSD
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:800 seeds LSA - My First Trip Ever
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
MDMA
JWH-073
2C-E
DOC
Amanita muscaria
MiPLA
Experience:1mg 25c-NBOMe - Experiment in my room
JWH-018
2C-I
MPT
Enhancement of colour rose.jpgRose by Chelsea Morgan
4-FA
MiPT
PRO-LAD
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
ΑMT
Experience:2 tabs DOB - My DOB Nightmare
25B-NBOH
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
TMA-2
4-HO-MPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
EPT
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Mescaline
2C-T-7
Memantine
3-MMC
DOI
25D-NBOMe
Psilocin
Experience:25mg 3-MeO-PCP - Enhanced film experience
25C-NBOMe
ALD-52
4-HO-DiPT
ETH-LAD
THJ-018
Experience:4x 200ug tabs - You do not need to understand
GABAergic hallucinogens
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Selective serotonin reuptake inhibitor
THJ-2201
2C-T-2
1P-ETH-LAD
4-HO-DPT
Experience:3-MeO-PCP - Extreme psychosis
AL-LAD
4-HO-DET
Proscaline
4-AcO-DiPT
25I-NBOH
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
4-HO-EPT
5F-PB-22
DET
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Efavirenz
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Cannabis
Phenethylamine (compound)
Paradise island by Xanny.jpgParadise island by Subsentience
DPT
Experience:4.5g - The Grand Introduction to Beauty and Fear
Aniracetam
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Methallylescaline
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
1P-LSD
DOM
5-MeO-DiPT
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
5-Hydroxytryptophan
Ibogaine
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
2C-H
Bromo-DragonFLY
MDA
5-MeO-DALT
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
MDEA
Experience:4-HO-MiPT / A care free psychedelic getaway
LSM-775
25B-NBOMe
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
DiPT
DMT
Piracetam
MET
Omberacetam
2C-B
PARGY-LAD
Experience:300µg LSD - Togetherness and the Silent Dusk
LSA

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.